New findings on lymph node cancer

As part of a research project funded with €151,000 by the Wilhelm Sander Foundation at the José Carreras Centre of the Department of Internal Medicine I at Saarland University Hospital (UKS), have succeeded in identifying a possible further infectious trigger for Hodgkin’s lymphoma: the bacterium Rothia mucilaginosa. Furthermore, in the case of mantle cell lymphoma, it has been shown that reactivity of lymphoma B-cell receptors against a specific endogenous protein (LRPAP1) is associated with a better prognosis. These findings could also be used in the future to develop new therapeutic approaches for the treatment of lymph node cancer.